CLSDQ
Clearside Biomedical, Inc.
Key Financials
EPS (Diluted)
$-0.47
↑ 11.3%
Revenue
$1.7M
↓ 79.8%
Operating Income
$-28882000
↓ 16.3%
Net Income
$-34352000
↓ 5.7%
Total Assets
$25.1M
↓ 26.1%
Total Liabilities
$64.0M
↑ 28.1%
Cash & Equivalents
$20.0M
↓ 30.8%
Shareholders' Equity
$-38855000.00
↓ 144.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CLSDQ |
| Company Name | Clearside Biomedical, Inc. |
| CIK | 1539029 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 678-270-3631 |